Glucagon secretory response to hypoglycaemia, adrenaline and carbachol in streptozotocin-diabetic rats

B. Ahren, J. S. Stern, R. L. Gingerich, D. L. Curry, Peter J Havel

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Glucagon response to insulin-induced hypoglycaemia is impaired in diabetes, but the mechanism is not established. Pancreatic A cell hyporesponsiveness to adrenergic or cholinergic stimulation could contribute to the impairment. We therefore compared the plasma glucagon responses to intravenous infusion of adrenaline (1200 ng kg-1 min-1 for 20 min) or to intravenous injection of the cholinergic agonist carbachol (50 μg kg-1) in chloral hydrate-anaesthetized rats made diabetic with the use of streptozotocin (80 mg kg-1 subcutaneously) 6 weeks before and in anaesthetized control rats. Insulin was infused intravenously to reduce plasma glucose levels to below 1.8 mmol L-1. As expected, the plasma glucagon response was reduced by ~ 45% in streptozotocin-diabetic rats compared with controls (P = 0.045). During adrenaline infusion, plasma glucagon levels increased by 277 ± 92 pg mL-1 in controls (P=0.009) and by 570 ± 137 pg mL-1 in the diabetic rats (P = 0.002). Thus, the plasma glucagon response to adrenaline was approximately doubled in the diabetic rats (P = 0.045). Following carbachol injection, plasma glucagon levels were raised by 1211 ± 208 pg mL-1 (P < 0.001) in controls but only by 555 ± 242 pg mL-1 in the diabetic rats (P = 0.049). Thus, the plasma glucagon response to carbachol was impaired by ~ 58% in the diabetic rats (P = 0.028). We conclude that carbachol-stimulated glucagon secretion is impaired concomitantly with the impaired glucagon response to hypoglycaemia in streptozotocin-diabetic rats, whereas adrenaline-induced glucagon secretion is exaggerated. We suggest that a reduced pancreatic A cell responsiveness to cholinergic stimulation could contribute to the impairment of the glucagon response to insulin-induced hypoglycaemia in diabetes.

Original languageEnglish (US)
Pages (from-to)215-221
Number of pages7
JournalActa Physiologica Scandinavica
Volume155
Issue number2
StatePublished - 1995

Fingerprint

Carbachol
Streptozocin
Glucagon
Hypoglycemia
Epinephrine
Glucagon-Secreting Cells
Insulin
Cholinergic Agents
Chloral Hydrate
Cholinergic Agonists
Intravenous Infusions
Intravenous Injections
Adrenergic Agents
Glucose
Injections

Keywords

  • Adrenaline
  • Cholinergic
  • Diabetes
  • Glucagon secretion
  • Hypoglycaemia
  • Rats

ASJC Scopus subject areas

  • Physiology

Cite this

Glucagon secretory response to hypoglycaemia, adrenaline and carbachol in streptozotocin-diabetic rats. / Ahren, B.; Stern, J. S.; Gingerich, R. L.; Curry, D. L.; Havel, Peter J.

In: Acta Physiologica Scandinavica, Vol. 155, No. 2, 1995, p. 215-221.

Research output: Contribution to journalArticle

Ahren, B. ; Stern, J. S. ; Gingerich, R. L. ; Curry, D. L. ; Havel, Peter J. / Glucagon secretory response to hypoglycaemia, adrenaline and carbachol in streptozotocin-diabetic rats. In: Acta Physiologica Scandinavica. 1995 ; Vol. 155, No. 2. pp. 215-221.
@article{7fe7f54b7b27464c8baf3b5aaff63c0d,
title = "Glucagon secretory response to hypoglycaemia, adrenaline and carbachol in streptozotocin-diabetic rats",
abstract = "Glucagon response to insulin-induced hypoglycaemia is impaired in diabetes, but the mechanism is not established. Pancreatic A cell hyporesponsiveness to adrenergic or cholinergic stimulation could contribute to the impairment. We therefore compared the plasma glucagon responses to intravenous infusion of adrenaline (1200 ng kg-1 min-1 for 20 min) or to intravenous injection of the cholinergic agonist carbachol (50 μg kg-1) in chloral hydrate-anaesthetized rats made diabetic with the use of streptozotocin (80 mg kg-1 subcutaneously) 6 weeks before and in anaesthetized control rats. Insulin was infused intravenously to reduce plasma glucose levels to below 1.8 mmol L-1. As expected, the plasma glucagon response was reduced by ~ 45{\%} in streptozotocin-diabetic rats compared with controls (P = 0.045). During adrenaline infusion, plasma glucagon levels increased by 277 ± 92 pg mL-1 in controls (P=0.009) and by 570 ± 137 pg mL-1 in the diabetic rats (P = 0.002). Thus, the plasma glucagon response to adrenaline was approximately doubled in the diabetic rats (P = 0.045). Following carbachol injection, plasma glucagon levels were raised by 1211 ± 208 pg mL-1 (P < 0.001) in controls but only by 555 ± 242 pg mL-1 in the diabetic rats (P = 0.049). Thus, the plasma glucagon response to carbachol was impaired by ~ 58{\%} in the diabetic rats (P = 0.028). We conclude that carbachol-stimulated glucagon secretion is impaired concomitantly with the impaired glucagon response to hypoglycaemia in streptozotocin-diabetic rats, whereas adrenaline-induced glucagon secretion is exaggerated. We suggest that a reduced pancreatic A cell responsiveness to cholinergic stimulation could contribute to the impairment of the glucagon response to insulin-induced hypoglycaemia in diabetes.",
keywords = "Adrenaline, Cholinergic, Diabetes, Glucagon secretion, Hypoglycaemia, Rats",
author = "B. Ahren and Stern, {J. S.} and Gingerich, {R. L.} and Curry, {D. L.} and Havel, {Peter J}",
year = "1995",
language = "English (US)",
volume = "155",
pages = "215--221",
journal = "Acta Physiologica Scandinavica",
issn = "0370-839X",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Glucagon secretory response to hypoglycaemia, adrenaline and carbachol in streptozotocin-diabetic rats

AU - Ahren, B.

AU - Stern, J. S.

AU - Gingerich, R. L.

AU - Curry, D. L.

AU - Havel, Peter J

PY - 1995

Y1 - 1995

N2 - Glucagon response to insulin-induced hypoglycaemia is impaired in diabetes, but the mechanism is not established. Pancreatic A cell hyporesponsiveness to adrenergic or cholinergic stimulation could contribute to the impairment. We therefore compared the plasma glucagon responses to intravenous infusion of adrenaline (1200 ng kg-1 min-1 for 20 min) or to intravenous injection of the cholinergic agonist carbachol (50 μg kg-1) in chloral hydrate-anaesthetized rats made diabetic with the use of streptozotocin (80 mg kg-1 subcutaneously) 6 weeks before and in anaesthetized control rats. Insulin was infused intravenously to reduce plasma glucose levels to below 1.8 mmol L-1. As expected, the plasma glucagon response was reduced by ~ 45% in streptozotocin-diabetic rats compared with controls (P = 0.045). During adrenaline infusion, plasma glucagon levels increased by 277 ± 92 pg mL-1 in controls (P=0.009) and by 570 ± 137 pg mL-1 in the diabetic rats (P = 0.002). Thus, the plasma glucagon response to adrenaline was approximately doubled in the diabetic rats (P = 0.045). Following carbachol injection, plasma glucagon levels were raised by 1211 ± 208 pg mL-1 (P < 0.001) in controls but only by 555 ± 242 pg mL-1 in the diabetic rats (P = 0.049). Thus, the plasma glucagon response to carbachol was impaired by ~ 58% in the diabetic rats (P = 0.028). We conclude that carbachol-stimulated glucagon secretion is impaired concomitantly with the impaired glucagon response to hypoglycaemia in streptozotocin-diabetic rats, whereas adrenaline-induced glucagon secretion is exaggerated. We suggest that a reduced pancreatic A cell responsiveness to cholinergic stimulation could contribute to the impairment of the glucagon response to insulin-induced hypoglycaemia in diabetes.

AB - Glucagon response to insulin-induced hypoglycaemia is impaired in diabetes, but the mechanism is not established. Pancreatic A cell hyporesponsiveness to adrenergic or cholinergic stimulation could contribute to the impairment. We therefore compared the plasma glucagon responses to intravenous infusion of adrenaline (1200 ng kg-1 min-1 for 20 min) or to intravenous injection of the cholinergic agonist carbachol (50 μg kg-1) in chloral hydrate-anaesthetized rats made diabetic with the use of streptozotocin (80 mg kg-1 subcutaneously) 6 weeks before and in anaesthetized control rats. Insulin was infused intravenously to reduce plasma glucose levels to below 1.8 mmol L-1. As expected, the plasma glucagon response was reduced by ~ 45% in streptozotocin-diabetic rats compared with controls (P = 0.045). During adrenaline infusion, plasma glucagon levels increased by 277 ± 92 pg mL-1 in controls (P=0.009) and by 570 ± 137 pg mL-1 in the diabetic rats (P = 0.002). Thus, the plasma glucagon response to adrenaline was approximately doubled in the diabetic rats (P = 0.045). Following carbachol injection, plasma glucagon levels were raised by 1211 ± 208 pg mL-1 (P < 0.001) in controls but only by 555 ± 242 pg mL-1 in the diabetic rats (P = 0.049). Thus, the plasma glucagon response to carbachol was impaired by ~ 58% in the diabetic rats (P = 0.028). We conclude that carbachol-stimulated glucagon secretion is impaired concomitantly with the impaired glucagon response to hypoglycaemia in streptozotocin-diabetic rats, whereas adrenaline-induced glucagon secretion is exaggerated. We suggest that a reduced pancreatic A cell responsiveness to cholinergic stimulation could contribute to the impairment of the glucagon response to insulin-induced hypoglycaemia in diabetes.

KW - Adrenaline

KW - Cholinergic

KW - Diabetes

KW - Glucagon secretion

KW - Hypoglycaemia

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=0028807543&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028807543&partnerID=8YFLogxK

M3 - Article

C2 - 8669294

AN - SCOPUS:0028807543

VL - 155

SP - 215

EP - 221

JO - Acta Physiologica Scandinavica

JF - Acta Physiologica Scandinavica

SN - 0370-839X

IS - 2

ER -